Draining Brain Toxins May Slow Alzheimer's
Posted on: Wednesday, 25 August 2004, 06:00 CDT
Cognitive test scores remained stable in treated patients
HealthDayNews -- Reducing levels of specific toxins in the brain may help stabilize cognitive decline in Alzheimer's disease patients.
That's the finding of preliminary research from the University of Pennsylvania School of Medicine, published in the August issue of the Journal of Alzheimer's Disease.
The toxins under study are called isoprostanes, compounds that accumulate in the brains of people with Alzheimer's disease and cause the death of cells involved in memory and language.
Researchers controlled the levels of isoprostanes in eight Alzheimer's patients by fitting them with specially designed shunts that drained their cerebral spinal fluid. Over a year, isoprostane levels in these patients declined by about 50 percent, compared to Alzheimer's patients who took only standard oral medications.
In a paper-and-pencil cognitive test, the scores of the patients with the shunts remained stable over 12 months. The scores of patients without the shunt declined by 20 percent.
Nearly 100 Alzheimer's patients have been recruited for the next phase of the study, which is being conducted at Stanford University.
-----
On the Net:
U.S. National Institute on Aging
University of Pennsylvania School of Medicine
More science, space, and technology from RedNova
Copyright © 2004 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment.
Related Articles
- Exercise Assist Patients With Non-Alcoholic Fatty Liver Disease
- First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
- Clinical Data Indicate That Percutaneous Coronary Intervention With the CYPHER(R) Sirolimus-Eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients With Diabetes and Multi-Vessel Disease
- PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden
- CORRECTING and REPLACING Reversal of Alzheimer's Cognitive Decline By New Treatment Suggested in Small Human Pilot Study; Peer Reviewed Study Published By Medscape General Medicine
- Primary Prevention Trials: Lessons Learned About Treating High-Risk Patients With Dyslipidemia Without Known Cardiovascular Disease
- Newly Published Study Evaluates Extended Dosing Regimens of PROCRIT(R) (Epoetin Alfa) As Maintenance Treatment for Patients With Anemia From Chronic Kidney Disease
- Is There a Link Between Low Vitamin E Levels and Heart Disease?
- 'Molecular Zipper' May Hold Important Clues to Alzheimer's, Parkinson's and Mad Cow Disease
- Serum Lipoprotein (a) Levels in Liver Diseases Caused By Hepatitis
 |
 |
User Comments (0)
RSS Feeds